0
JAMA Clinical Challenge |

A 23-Year-Old Woman With a Right Femoral Neck Fracture FREE

Shi Wei, MD, PhD; Gene P. Siegal, MD, PhD
[+] Author Affiliations

Author Affiliations: Department of Pathology, University of Alabama at Birmingham, and UAB Center for Metabolic Bone Disease, Birmingham.


JAMA. 2011;306(21):2385-2386. doi:10.1001/jama.2011.1748.
Text Size: A A A
Published online
Figures in this Article

A 23-year-old woman was referred for evaluation of a right femoral neck pathologic fracture. Review of her pelvic computed tomography (CT) scan from the referring hospital revealed multiple lytic bony lesions in her pelvis bilaterally and in both proximal femurs and a right femoral neck fracture (Figure 1). On admission, she had an elevated serum calcium level (14.8 mg/dL; normal range, 8.5-10.1 mg/dL [to convert to mmol/L, multiply by 0.25]), decreased serum phosphorus level (2.3 mg/dL; normal range, 2.5-4.9 mg/dL [to convert to mmol/L, multiply by 0.323]), serum creatinine within normal limits, and an undefined anemia (hemoglobin, 7.8 g/dL; normal range, 11.3-15.2 g/dL). She was treated with intravenous fluids, pamidronate for her hypercalcemia, and a blood transfusion for her anemia. She then underwent a hemiarthroplasty.

Place holder to copy figure label and caption
Figure 1. Computed tomography scan showing multiple lytic bony lesions in the pelvis and proximal femurs and a right femoral neck fracture.
Grahic Jump Location

A . Laboratory studies to rule out multiple myeloma
B . Laboratory studies to rule out primary hyperparathyroidism
C . A skeletal survey with conventional radiographs and CT scan
D. All of the above

Primary hyperparathyroidism (PHPT) of unusually early presentation

D. All of the above

The key diagnostic feature is knowing the differential diagnosis in a patient with hypercalcemia, hypophosphatemia, and multiple lytic lesions throughout the skeleton includes PHPT. The diagnosis of PHPT was confirmed by the subsequent laboratory findings of a markedly elevated serum parathyroid hormone (PTH) level (1492 pg/mL; normal range, 12-90 pg/mL) and an increased serum level of 1,25-dihydroxyvitamin D (97 pg/mL; normal range, 18-72 pg/mL [to convert to pmol/L, multiply by 2.6]). The decision was further supported by the sonographic finding of a 2.2-cm hypoechoic lesion adjacent to the left thyroid lobe.

The prevalence of PHPT varies by age and sex. Women are more commonly affected than men, with a peak incidence between 50 and 60 years of age.1 The annual incidence among patients younger than 40 years is reportedly less than 10 per 100 000.2 In a young patient, the findings might also represent skeletal manifestations of a genetic disease, such as polyostotic fibrous dysplasia in the setting of McCune-Albright syndrome. Parathyroid hormone induces serum calcium by stimulating the release of calcium from bone matrix, increasing calcium and decreasing phosphate reabsorption by the kidney, and indirectly facilitating calcium absorption from the small intestine by stimulating renal production of 1,25-dihydroxyvitamin D.3 Primary hyperparathyroidism is usually caused by a parathyroid adenoma and less frequently by hyperplasia or carcinoma. The excess PTH secretion leads to hypercalcemia in the absence of significant renal dysfunction, thus resulting in the symptoms and signs summarized by the mnemonic “stones, bones, abdominal groans, and psychiatric moans,” which refers to nephrolithiasis, bone-related complications, gastrointestinal symptoms, and effects on the central nervous system. Serum phosphorus levels are commonly low in PHPT due to the phosphaturic effect of PTH on the kidney. Moderate anemia may be seen in severe PHPT. The etiology for the anemia remains unknown; however, marrow fibrosis is thought to play a key role because it is common in such patients and has been seen to improve after parathyroidectomy.4

The effects of PHPT on bone largely depend on the duration of the disease and the serum level of PTH, which targets osteoblasts and induces the osteoclastogenic cytokine RANKL (receptor activator of nuclear factor κB ligand).5 Bone changes may not be identified in the early stages. As the disease progresses, common findings include diffuse osteopenia, bone pain, and pathologic fractures. Multifocal subperiosteal resorption is generally considered to be pathognomonic of PHPT. The earliest bone changes are typically visible in the hands, particularly in the phalanges and terminal tufts.6 Skeletal changes without hand changes are rare. The classic histologic appearance of long-standing PHPT in bone is “tunneling” resorption (bony trabeculae replaced in the center by fibrovascular connective tissue) and peritrabecular fibrosis. In more severe cases, lytic lesions with cyst formation (osteitis fibrosa cystica) and/or with prominent multinucleated giant cells (simulating a giant cell reparative granuloma) may be seen and are termed “brown tumors” due to their gross appearance caused by hemorrhagic debris.

Differential diagnosis in a young person with hypercalcemia includes multiple myeloma, familial hypocalciuric hypercalcemia, and hyperparathyroidism-jaw tumor syndrome. The latter are both autosomal dominant disorders.1,7 Thus, genetic counseling and appropriate imaging and laboratory studies are needed. Once PHPT is diagnosed, the only cure is surgical removal of the parathyroid lesion. Medical treatment is reserved for patients who do not meet operative criteria.89 The diagnosis of PHPT in this patient was further complicated by the pathologic diagnosis of an aneurysmal bone cyst from the right femoral lesion, which represented a brown tumor largely replaced by a secondary aneurysmal bone cyst. A large left mandible exophytic mass was also found, the excisional biopsy of which demonstrated a giant cell reparative granuloma-like brown tumor (Figure 2). Surgical excision of the neck mass revealed a 1.34-g parathyroid adenoma. No monoclonal immunoglobulin was identified by serum or urine protein electrophoresis.

Place holder to copy figure label and caption
Figure 2. Histologic appearance of left mandible mass (hematoxylin-eosin, original magnification ×100).
Grahic Jump Location

Corresponding Author: Shi Wei, MD, PhD, University of Alabama, Birmingham, Department of Pathology, NP 3542, 1802 Sixth Ave S, Birmingham, AL 35249-7331 (swei@uab.edu).

Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Fraser WD. Hyperparathyroidism.  Lancet. 2009;374(9684):145-158
PubMed
Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community.  N Engl J Med. 1980;302(4):189-193
PubMed
Peacock M. Calcium metabolism in health and disease.  Clin J Am Soc Nephrol. 2010;5(suppl 1)  S23-S30
PubMed
Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, Dutta P. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.  Clin Endocrinol (Oxf). 2009;70(4):527-532
PubMed
Eriksen EF. Cellular mechanisms of bone remodeling.  Rev Endocr Metab Disord. 2010;11(4):219-227
PubMed
Hayes CW, Conway WF. Hyperparathyroidism.  Radiol Clin North Am. 1991;29(1):85-96
PubMed
Szabó J, Heath B, Hill VM,  et al.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.  Am J Hum Genet. 1995;56(4):944-950
PubMed
Davies M, Fraser WD, Hosking DJ. The management of primary hyperparathyroidism.  Clin Endocrinol (Oxf). 2002;57(2):145-155
PubMed
Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism.  Nat Clin Pract Endocrinol Metab. 2006;2(9):494-503
PubMed

Figures

Place holder to copy figure label and caption
Figure 1. Computed tomography scan showing multiple lytic bony lesions in the pelvis and proximal femurs and a right femoral neck fracture.
Grahic Jump Location
Place holder to copy figure label and caption
Figure 2. Histologic appearance of left mandible mass (hematoxylin-eosin, original magnification ×100).
Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Fraser WD. Hyperparathyroidism.  Lancet. 2009;374(9684):145-158
PubMed
Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community.  N Engl J Med. 1980;302(4):189-193
PubMed
Peacock M. Calcium metabolism in health and disease.  Clin J Am Soc Nephrol. 2010;5(suppl 1)  S23-S30
PubMed
Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, Dutta P. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.  Clin Endocrinol (Oxf). 2009;70(4):527-532
PubMed
Eriksen EF. Cellular mechanisms of bone remodeling.  Rev Endocr Metab Disord. 2010;11(4):219-227
PubMed
Hayes CW, Conway WF. Hyperparathyroidism.  Radiol Clin North Am. 1991;29(1):85-96
PubMed
Szabó J, Heath B, Hill VM,  et al.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.  Am J Hum Genet. 1995;56(4):944-950
PubMed
Davies M, Fraser WD, Hosking DJ. The management of primary hyperparathyroidism.  Clin Endocrinol (Oxf). 2002;57(2):145-155
PubMed
Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism.  Nat Clin Pract Endocrinol Metab. 2006;2(9):494-503
PubMed
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Topics
PubMed Articles